User: TahirAmin Topic: IP
Category: drugs :: everywhere
Last updated: May 25 2017 11:56 IST RSS 2.0
 
1 to 20 of 9,643    
Lupin hits 33-month low on weak Q4 results 25.5.2017 Business Standard: Front Page Headlines
It past two months, the stock underperformed the market by falling 24% against 3% rise in Sensex.
Also found in: [+]
Weak US sales pull down Lupin show 24.5.2017 News
Operating performance in the March quarter also impacted by one-offs
Also found in: [+]
Ineffective remedy 24.5.2017 FrontLine: Home
The Prime Minister’s plans to enact a law to ensure that doctors prescribed only generic drugs will not have the desired impact without comprehensive action to make medicines affordable to all. By T.K. RAJALAKSHMI
Also found in: [+]
India's generics project can bring down medicine costs globally: WHO India head (IANS Interview) 24.5.2017 All News-IANS Stories
As the government gears up to push generic medicines to bring down costs for patients, World Health Organisation (WHO) representative in India Henk Bekedam has stated that the move, if successfully implemented, will not only reduce the cost of medicines within the country but also globally.
Also found in: [+]
'What we do is determined by national interest' 24.5.2017 Rediff: Business
If people can lobby me for making changes in policies that goes against the country's interest, I won't keep myself in this position, says the vice chairman of NITI Aayog.
Also found in: [+]
Molecule discovery offers Ithope for Parkinson's cure 23.5.2017 TOI: Bangalore Times
City scientists have found a new molecule that can enhance the efficiency of the autophagy process in brain cells, that can significantly reduce their degeneration, which is the cause of diseases like Parkinson's.
Also found in: [+]
Scientists discover molecule which shows hope for Parkinson’s cure 23.5.2017 TOI: Bangalore Times
Also found in: [+]
Sebi drops insider trading case against Aurobindo Pharma's promoter 22.5.2017 Latest News
40,000 share option contract in derivatives of Aurobindo Pharma were traded before quarterly results
Also found in: [+]
NAFTA's biggest loser: US, after Canada, Mexico get rich trading marijuana 17.5.2017 Latest News
If all of this sounds bad for American investors and patients, it's good news for Mexico and Canada
Also found in: [+]
Won't do anything against national interest: NITI Aayog VC Panagariya 16.5.2017 Business Standard: Today
Interview with vice-chairman, NITI Aayog
Also found in: [+]
Many unaware of city's Jan Aushadhi, Amrit stores 14.5.2017 DNA: Money
The Amrit store, which is located inside the premises of ESIS Hospital in Worli, wore a deserted look when DNA visited on a weekday morning. The store is an initiative of the central government and drugs are procurred directly through government-owned company HLL. AMRIT is known for affordable medicines and reliable implants for treatment. It cuts short the chain of middlemen and offers anywhere between 15 to 75 per cent discount on both branded and generic drugs but most consumers seem unaware. "We opened the store during BMC elections but we were not able to publicise it due to the election code of conduct," said the marketing head for Maharashtra region who chose to remain anonymous. "We are able to offer heavy discounts but the demand has not yet picked up," he added. There is another AMRIT store at ESIS hospital in Mulund as well as one in Nagpur. Mumbai also has three other Jan Audhashi stores — at Ghatkopar, Borivli and Malad, apart from the 1,200 stores that have been opened across the ...
Also found in: [+]
Roche vs Indian Pharma: The battle for a cheaper cancer drug 14.5.2017 ET: Pharma
The companies in the thick of it are Roche, a $51 billion Swiss pharma major, and Biocon, the Bengaluru-based company led by India’s first woman pharma-billionaire, Kiran Mazumdar-Shaw.
Also found in: [+]
Fit & proper: Tackling neurological disorders 13.5.2017 All Current Affairs Stories
Compared to other therapeutic fields, neurological diseases are under-researched
Also found in: [+]
'India's IPR policy a good first step, needs to address gaps' 13.5.2017 ET: Policy
Both, the companies in the United States and the Trump administration have been expressing concerns over some aspects of the Indian IPR policy.
Also found in: [+]
Dr Reddy's aims to launch 10 products in US in 2017 after 'bad year' 12.5.2017 All Companies Stories
Dr Reddy's says US drug approvals are hard to get after
Also found in: [+]
What’s in a generic name? 12.5.2017 Hindu: Home
The core issues are affordable access to medicines and their rational prescription and use
Also found in: [+]
Kurian bats for generic drugs 10.5.2017 Hindu: Kerala
Calls for ban on drug firms marketing `branded generic drugs’
Also found in: [+]
Zydus wins patent battle, can now launch ulcerative colitis drug in US 10.5.2017 News
American court says proposed generic version of Lialda (mesalamine) is not a case of infringement
Also found in: [+]
US Court rules in favour of Zydus in ulcerative colitis drug patent case 10.5.2017 Latest News
It ruled that Zydus' generic version of Lialda (mesalamine) does not infringe patent of Shire
Also found in: [+]
US court rules in favour of drug firm Zydus Cadila in patent case 10.5.2017 News
The Court of Appeals' decision is a major step toward Zydus providing a generic version of Lialda
Also found in: [+]
1 to 20 of 9,643